Clinical Study
CSL-964
A study to evaluate the safety and efficacy of Alpha 1 Antitrypsin for the prevention of graft versus host disease in patients receiving hematopoietic cell transplant
For more information contact:
Sharada Dixit
sharada.dixit@hsc.utah.edu
801.587.7525
IRB#: IRB_00125273
| PI: AHMAD RAYES
| Department: UNIVERSITY OF UTAH (PRESIDENT)
| Approval Date: 2020-07-01 06:00:00
Study Categories: All Cancer Studies
| Specialties: Pediatric Hematology & Oncology
Who can participate?
Gender: All
Age: Over 7 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
Yes